Skip to main content

and
  1. Article

    Open Access

    Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

    One target of rheumatoid arthritis (RA) treatment is to achieve early sustained remission; over the long term, patients in sustained remission have less structural joint damage and physical disability. We eval...

    Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk in Rheumatology and Therapy (2023)

  2. No Access

    Article

    Randomized controlled trial investigating use of submucosal injection of EverLift™ in rates of complete resection of non-pedunculated 4–9 mm polyps

    Currently, cold snare polypectomy (CSP) without submucosal injection is recommended for removing polyps < 10 mm. Use of viscous submucosal agents has not been previously evaluated in CSP. We investigate the po...

    Mike T. Wei, Christine Y. Louie, Yu Chen in International Journal of Colorectal Disease (2022)

  3. No Access

    Article

    Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis

    Juvenile idiopathic arthritis (JIA) encompasses several forms of chronic inflammatory arthritis of unknown etiology presenting in children < 16 years of age, with a minimum symptom duration of 6 weeks. Approxi...

    Hermine I. Brunner, Robert Wong, Marleen Nys, Tzuyung D. Kou in Pediatric Drugs (2020)